PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Ark Therapeutics plc

20 Feb 2013 12:54

ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plc

ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plc

PR Newswire

London, February 20

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A

PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/ Aberforth Partners LLP, ondealings are being disclosed:

behalf of discretionary clients.(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):The naming of nominee or vehicle companies isinsufficient

(c) Name of offeror/offeree in relation to Ark Therapeutics Group plcwhose relevant securities this form relates:

Use a separate form for each offeror/offeree(d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree:(e) Date position held/dealing undertaken: 19 February 2013(f) Has the discloser previously disclosed, or Y/N NOare they today disclosing, under the Code in

respect of any other party to this offer? If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares Interests Short positions Number % Number %(1) Relevant securities owned 20,580,092 9.83 0 0.0and/or controlled:(2) Derivatives (other thanoptions):(3) Options and agreements topurchase/sell:TOTAL: 20,580,092 9.83 0 0.0

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions).

(b) Rights to subscribe for new securities (including directors' and otherexecutive options)

Class of relevant security in N/Arelation to which subscription rightexists:Details, including nature of the N/Arights concerned and relevantpercentages:

If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit security securities Ordinary Shares Sale 4,000,000 0.7812p

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price

date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A(ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call optionN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit

security (if applicable) e.g. subscription, conversion N/A

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options orderivatives

Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None(c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached? Y/N NODate of disclosure: 20 February 2013Contact name: David Holland, for Aberforth Partners LLPTelephone number: 0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
21st Jul 201010:54 amRNSForm 8.5 (EPT/NON-RI)
20th Jul 201011:35 amRNSForm 8.5 (EPT/NON-RI)
20th Jul 201011:00 amRNSForm 8.5 (EPT/RI)
20th Jul 201010:46 amRNSForm 8.3 - [Ark Therapeutics]
19th Jul 201011:39 amRNSForm 8.5 (EPT/RI)
19th Jul 201011:33 amRNSForm 8.5 (EPT/RI)- Amendment 15/07
19th Jul 201011:26 amRNSForm 8.3 - Ark Therapeutics
16th Jul 201012:07 pmRNSForm 8.5 (EPT/RI)
15th Jul 20101:06 pmRNSForm 8.3 - Ark Therapeutics Group PLC
13th Jul 20107:00 amRNSARK UPDATE AND BOARD CHANGES
9th Jul 201010:16 amRNSForm 8.3 - Ark Therapeutics Group PLC - Amendment
8th Jul 201010:27 amRNSForm 8.3 - Ark Therapeutics Group PLC
7th Jul 20101:54 pmPRNForm 8.3 - Ark Therapeutic Group Plc
7th Jul 201011:50 amRNSForm 8.5 (EPT/NON-RI)
6th Jul 20102:49 pmPRNForm 8.3 - Ark Therapeutics Groups Plc
6th Jul 201011:36 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20102:15 pmPRNForm 8.3 - Ark Therapeutic Group Plc
2nd Jul 201011:45 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 201011:36 amRNSForm 8.5 (EPT/RI)
30th Jun 20102:45 pmPRNForm 8.3 - Ark Therapeutic Group
30th Jun 201011:45 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 20103:06 pmPRNForm 8.3 - Ark Therapeutic Group Plc
25th Jun 20102:34 pmPRNForm 8.3 - Ark Therapeutics Group Plc
25th Jun 201010:52 amRNSForm 8.5 (EPT/RI)-Amendment
24th Jun 201011:39 amRNSForm 8.5 (EPT/NON-RI)
24th Jun 201010:23 amRNSForm 8.5 (EPT/RI)
23rd Jun 201011:45 amRNSForm 8.5 (EPT/NON-RI)
23rd Jun 201011:39 amRNSForm 8.5 (EPT/RI)
22nd Jun 20102:50 pmPRNForm 8.3 - Ark Therapeutics
22nd Jun 201011:41 amRNSForm 8.5 (EPT/RI)
21st Jun 20102:48 pmRNSForm 8.3 - Ark Therapeutics Group plc
21st Jun 20102:07 pmPRNForm 8.3 - ARK THERAPEUTIC PLC
21st Jun 20101:16 pmRNSForm 8.3 - Ark Therapeutics Plc
21st Jun 201010:48 amRNSForm 8.5 (EPT/RI)
18th Jun 20102:33 pmPRNForm 8.3 - Ark Therapeutics Group Plc
18th Jun 201012:19 pmRNSForm 8.3 - Ark Therapeutics Plc
18th Jun 201011:45 amRNSForm 8.5 (EPT/NON-RI)
18th Jun 201011:02 amRNSHolding(s) in Company
17th Jun 20102:42 pmPRNForm 8.3 - Ark Therapeutics Group
17th Jun 20102:41 pmRNSForm 8.3 - Ark Therapeutics Group PLC
17th Jun 20101:47 pmRNSForm 8.3 - Ark Therapeutics Plc
17th Jun 201011:32 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 201011:25 amRNSForm 8.5 (EPT/RI)
16th Jun 20109:19 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 20103:12 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Jun 20102:43 pmPRNForm 8.3 - Ark Therapeutics Group Plc
15th Jun 201012:38 pmRNSForm 8.3 - Ark Therapeutics Plc
15th Jun 20109:47 amRNSForm 8.5 (EPT/NON-RI)
14th Jun 20103:08 pmRNSForm 8.3 - Ark Therapeutics Group PLC
14th Jun 20101:30 pmRNSForm 8.3 - Ark Therapeutics Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.